Oxytetracycline hasbeen suggestedasanalternate therapy for chronic recurrent sialadenitis and sialorrhea. Weconducted an experimental study to investigate the sclerotic effect of this drug on the submandibulargland by histopathologic methods. Our subjects were 20 New Zealand white rabbits, which weredivided into two groups of 1O. TIle rightsubmandibularglandoftherabbits in theactivetreatmentgroup wasinjectedwith0.3mlofoxytetracycline (JOO mg/ml), and that of the controls was injected with saline. Four weeks afterthe injections, alltheglandswere removed. Histopathologicstudies. including hematoxylin and eosin and Masson trichrome staining. were carried out. TIle glands were evaluatedfor tissue inflammation. congestion, fibrosis, edema, lipomatosis, and atrophy. To investigate apoptosis, terminal deoxynu cleotidyl transferase-mediated dUTP-digoxigenin nick-end labeling (TUNEL) immunohistochemical staining was used. In the study group, inflammation (n = 9), congestion (n = 9), fibrosis (n = 6), edema (n = 6), and lipomatosis (n = 4) were observed; in the sham group, only lipomatosis wnsseen (n = 5). The TUNELassny resultsfor acinarcells were4.51± 1.41 % in theoxytetracyclinegroupand 2.08± 1.76%in thecontrol group(p =0.006);thecorresponding figuresfor the duct cells were 7. 05 ± 0.87% and 3.10 ± 2.26% (p = 0.00l). Based on ourfindings, we conclude that oxytetracycline might be n viable alternativefor the treatmentofchronicrecurrentsialadenitisandsialorrhea. However, more research in this nrea is needed.
Introduction
Oxytetracycline is a commonly used sclerotic agent. It is preferred for sclerotherapy in numerous pathologies, including malignant pleural effusions, renal cysts, and lymphatic malformations of the head and neck.' :' Some authors have sugge sted that the sclerotic action of oxytetracycline is tr iggered by its extremely low pH level.~However, Keller contended that its sclerotic effects are attributable to more than low pl-l." While its exact mechanisms in this situation are unclear, it is known that oxytetracycline does cause a tissue reaction.
Oxytetracycline as a sclerosant can be used to treat some salivary gland pathologies such as chronic recurrent sialadenitis and sialorrhea. Chronic recurrent sialaden iti s is defined as recurrent nonobstructive salivary gland inflammation with or without a seco ndary bacterial infection. Common complaints of patients with chronic recurrent sialadenitis include a sensation of tension or discomfort during meals and recurrent acute attacks characterized by swelling, pain, and tenderness.
The usual therapies for chronic recurrent sialadenitis are sialagogues, gland massage, increased fluid intake and, if necessary, antibiotics. However, so metimes these therapies fail to prevent episodes, and clinicians mu st in itiate other treatments before opting for major surgery such as a parotidectomy or submand ibular gland excision. Relatively conservative approaches such as duct ligation, radiotherapy, and neurectomy are designed to produce parenchymal atrophy, which will alleviate symptoms by causing secretory ablation." Sialorrhea (drooling) is the involuntary loss of saliva from the mouth after infancyor after oral-motor maturation occurs. Sialorrhea is a problem for developmentally disabled children and adults.' Drooling usually occurs as a result of some form of neurologic disturbance, either central (e.g., cerebral palsy) or peripheral (e.g., facial palsy). " The prevalence of moderate to severe sialor-rhea in the population is estimated to range between 10 and 37%.7Treatments include pharmacologic therapy, tympanic neurectomy, corda tympani section, duct ligation, botulinum toxin injection, and major salivary gland excision.
There is a paucity of research in the literature about the effects of oxytetracycline on salivary gland pathologies. In this article, we describe our study to evaluate the sclerotic effects of oxytetracycline injection on rabbit submandibular glands by histopathologic methods. We theorized that if oxytetracycline induces atrophic and hypofunctional effects on gland tissue , it might be useful as an option for the treatment of chronic recurrent sialadenitis and sialorrhea.
Materials and methods
Twenty New Zealand white rabbits weighing 2.5 to 3 kg were used in this study. All animals were kept in optimum conditions in our laboratory.The animals were divided into two groups:an active-treatment group that received oxytetracycline (n = 10) and a sham group that received saline (n = 10).
Surgicalprocedure. Anesthesia wasadministered with 12.5 mg/kg of intramuscular xylazine and 100 mg/kg of ketamine. We then made a midline incision on the neck. Afterpassing through the skin and under the skin tissues, we identified the right submandibular gland under the superficial fascia in the submandibular triangle. In the active-treatment group, 0.3 ml of oxytetracycline (lOO mg/rnl) was injected into the gland. For the sham group, all surgical procedures were identical except for the injection of 0.3 ml of saline instead of oxytetracycline.
Four weeks later, we extirpated the submandibular glands for histopathologic investigation.
Histopathology. The submandibular gland samples were fixed in neutral buffered formalin (10% formaldehyde) . Following fixation, the tissue was trimmed and processed by standard paraffin-embedding methods. Sections were cut at 4 flm and then stained with hematoxylin and eosin and Masson trichrome. The active-treatment and control specimens were examined under a light photomicroscope (Axio Scope; Carl Zeiss; Oberkochen, Germany) at x4 to x40 magnification in a double-blind fashion. Histologic features (figures 1-3) such as acinar and duct cell inflammation, congestion, fibrosis, edema, lipomatosis, and atrophy were evaluated on a semiquantitative scale: negative or absent reactivity. low reactivity. moderate reactivity, and strong reactivity.
Immunohistochemistry. To examine apoptotic cells, the modified terminal deoxynucleotidyl transferase-mediated dUTP-digoxigenin nick-end labeling (TUNEL) method"was used with the ApopTag Plus Peroxidase In Situ Apoptosis Detection Kit (EMD Millipore; Darmstadt, Germany). Approximately 500 acinar cellsand 500 duct cells in four randomly chosen fields were counted at x400 magnification (CX41 Microscope; Olympus; Tokyo) on sections stained with TUNEL from each animal (figure 4). The TUNEL labeling index for each cell type was calculated. The mean of the labeling index from the four fieldswas taken as the representative value for each animal."
Statistical analysis. Statistical analysis was performed with the Statistical Package for the Social Sciences software (v, 16) . The mean and standard deviation were calculated for each group. The Mann-Whitney U test was used to determine significant differences between the groups. The results were evaluated at a significance level of p < 0.05. -.
thorized by the Canakkale Onsekiz Mart University's Animal Ethics Committee.
Results . In the oxytetracycline group, histopathology of the gland tissues identified inflammation in 9 rabbits, congestion in 9, fibrosis in 6, edema in 6, and lipomatosis in 4. The only such finding in the sham group was lipomatosis in 5 rabbits (table 1) . Atrophy was not detected in any sample in either group. With respect to the positive findings, all but 1 specimen showed a low degree of reactivity; the exception was a moderate degree of lipomatosis in an oxytetracycline rabbit. In addition, we detected periductal fibrosis in 6 specimens in the oxytetracycline group and ductal metaplasia in 1 gland (figure 2).
The mean TUNEL labeling index was 4.51 ± 1.41% in the oxytetracycline group and 2.08 ± 1.76% in the sham group (p = 0.006); the corresponding figures for the duct cells were 7.05 ± 0.87% and 3.10 ± 2.26% (p = 0.001) (table 2).
Discussion
Quinn and Graham described the first administration oftetracycline directly to the salivary glands of humans in 1973. 11 They treated 6 adults and 4 children who had chronic recurrent sialadenitis with intraductal tetracycline instillation; the ir symptoms did not recur. In an experimental study, Bowling et al found on histopathology that acinar cell atrophy and inflammation occurred as a result of intraductal tetracycline administration to the salivary glands." Their study also suggested that intraductal tetracycline might be effective in relieving the symptoms of chronic recurrent sialadenitis. Methyl 494 " www.entjournal.com violet, another sclerotic agent, was administered as an intraductal instillation in a study by Wang et al." They" found that a 1% methyl violet injection-induced atrophy in 16 patients with chronic recurrent sialadenitis, all of whom reported no recurrence.
Inflammation usually leads to hypofunction and atrophy. For example, patients with some nonautoimmune inflammatory diseases (e.g., sialolithiasis) and autoimmune inflammatory diseases (e.g., Sjogren syndrome, chronic sclerosant sialadenitis) are known to develop atrophy. 13 Moreover, an association between inflammation and salivary gland hypofunction was reported in a study ofCarpenter et al." They found increased cell inflammation and salivary gland hypofunction in the acute period after ductal ligation. They believed the reduction in gland secretions might have been the result of the effect of inflammatory cells on parenchymal functions.
In our study, we applied oxytetracycline injection directly into the submandibular gland tissue. Four weeks later, histopathologic investigation revealed inflammation, congestion, fibrosis, edema. and lipomatosis. In the sham group, only lipomatosis was observed. We did not find atrophy in either group, but this might be related to the small dose of the sclerosant and the relatively short length of the follow-up. The high degree ofTUNEL assay labeling that we found in the oxytetracycline group supports this possibility.
Bowling et al also reported ductal fibrosis in tetracycline-applied submandibular glands in their study," However, in our study, we also found fibrosis in the parenchyma,although this might have been attributable to the direct injection method we used.
In looking for apoptosis with the TUNEL assay, we stained both acinar and duct cells. In both cases, the of chronic recurrent sialadenitis and sialorrhea: • Botulinum toxin injection is reversible and requires repeated administrations.
• Neurectomies and ductal ligation are more invasive.
• Radiotherapy has serious side effects.
Important factors to consider in choosing a treatment include patient and physician preferences, the invasive nature of the treatment, success rates, and side effects.
According to the sialadenitis classification system developed by Seifert and Donath,16 we found only stage 1 and 2 changes in our study. Greater tissue responses might be possible by increasing the size of the dose or the number of doses; administering more than one dose 7.05 ± 0.87 3.10 ± 2.26 p =0.001 4 .51 ± 1.41 2.08 ± 1.76 p = 0.006 TUNEL score (%) --:Ac-c-=-in-a-r-c-e---:' I=-Is· -Duct cells Group Oxytetracycline Sham degree of staining was significantly greater in the oxytetracycline group, confirming the fact that this drug leads to apoptosis of both kinds of cells in the salivary gland. Takahashi et al used TUNEL staining and transmission electron microscopy after ductal ligation in rats and discovered that apoptosis occurred first in acinar cells and later in duct cells.IS They suggested that the transition of apoptosis from the acinar cells to the duct cells and the subsequent necrosis of the acinar cells play an important role in the atrophy of the sublingual gland. In both of our groups, atrophy was not evident, although apoptosis was present. If the length of our follow-up had been longer, we might have seen atrophy develop.
Injection into the salivarygland can be done manually or with ultrasound guidance. Compared with retrograde application, direct application has the advantage of allowing for better control of the dose. The risk of reflux in using the retrograde method makes measuring the effective dose more difficult. However, the retrograde method has the advantage of reaching all acinar cells as the material spreads through the entire ductal system. We believe that direct injection into several areas of the gland may overcome this disadvantage.
There are several noteworthy differences between oxytetracycline injections and other types of treatment can be easily achieved with our model.
One particular limitation ofour study isthat we did not evaluate the amount of saliva as a functional outcome.
Further research is need ed to increase our knowledge of oxytetracycline as a treatment for chronic recurrent sialaden itis and sialorrhea.
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